INVESTOR REMINDER: Berger Montague Notifies Beta Bionics, Inc. (BBNX) Investors of a Class Action Lawsuit and Deadline
As this information was revealed to investors, the price of Beta Bionics common stock declined, and investors suffered losses. Who is Beta Bionics? What do I need to do? Q&A What is this lawsuit about? This lawsuit concerns whether Beta Bionics and certain of its officers misled investors about the Company's automated insulin delivery system, known as the iLet Bionic Pancreas insulin pump, the Company's sole commercialized product. According to the complaint, after the Company disclosed that it had received ...